Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With MET Overexpression as a Second-line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
- Status
- COMPLETED
- Phase
- PHASE4
Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Fasting on Newly Diagnosed Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Micro RNAs to Predict Response to Androgen Deprivation Therapy
- Status
- COMPLETED
- Phase
- N/A
Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
- Status
- TERMINATED
- Phase
- NA